American officials will verify China's compliance with the agreement
Em um raro momento de convergência entre as duas maiores economias do mundo, Washington e Pequim formalizaram um acordo que entrelaça saúde pública e política comercial: os Estados Unidos reduzirão à metade as tarifas sobre produtos chineses em troca do compromisso da China de interromper o fluxo de precursores do fentanil. A medida, assinada por Trump em decreto executivo, nasce da cúpula entre Trump e Xi em Busan e reflete a compreensão de que crises humanas — como a epidemia de opioides — podem, às vezes, abrir brechas na rigidez das disputas geopolíticas. O que está em jogo não é apenas uma alíquota, mas a credibilidade de acordos firmados entre potências que desconfiam uma da outra.
- A epidemia de fentanil mata dezenas de milhares de americanos por ano, e a pressão para agir transformou o combate ao tráfico de precursores em prioridade máxima das negociações comerciais.
- A tarifa de 20% imposta por Trump como punição ao papel da China na cadeia de distribuição do opioide será cortada pela metade a partir de 10 de novembro — mas apenas se Pequim cumprir sua parte.
- O acordo, costurado na cúpula de Busan no mês passado, inclui um mecanismo de monitoramento conduzido por autoridades americanas, reconhecendo que a confiança diplomática, por si só, não é garantia suficiente.
- Para Trump, o acerto representa uma vitória dupla: reduzir custos para importadores e consumidores americanos enquanto avança em uma emergência doméstica de saúde pública.
- O risco permanece real — se a China não sustentar o cumprimento, as tarifas podem ser restabelecidas e a relação comercial entre as duas potências pode se deteriorar ainda mais.
Donald Trump assinou na terça-feira um decreto executivo que reduz à metade as tarifas adicionais impostas sobre produtos chineses, de 20% para 10%, formalizando o núcleo de um acordo mais amplo costurado após o encontro entre Trump e o presidente Xi Jinping em Busan, na Coreia do Sul, no mês passado.
A tarifa original havia sido a resposta de Washington ao que o governo americano descreveu como a participação da China na rede de distribuição de fentanil — o opioide sintético que se tornou uma das maiores crises de saúde pública dos Estados Unidos, ceifando dezenas de milhares de vidas por ano. A lógica era simples: pressionar economicamente para cortar o fluxo na origem.
Sob os termos agora formalizados, a China se comprometeu a interromper o envio de precursores químicos usados na fabricação do fentanil. Em contrapartida, os Estados Unidos reduzem as penalidades sobre importações chinesas, com a nova alíquota entrando em vigor no dia 10 de novembro. Trump destacou que autoridades americanas serão responsáveis por verificar o cumprimento do acordo — um mecanismo de monitoramento que reconhece os limites da confiança entre as duas potências.
O que ainda está por se provar é se o arranjo resistirá ao tempo. O incentivo da China é concreto — a redução tarifária representa um benefício econômico real. Mas acordos desse tipo já se mostraram frágeis no passado, e a cadeia de abastecimento de opioides é complexa e frequentemente opaca. Os próximos meses dirão se este momento de cooperação rara se transforma em virada genuína ou permanece como mais um capítulo da diplomacia performática entre Washington e Pequim.
Donald Trump signed an executive order on Tuesday that cuts in half the additional tariffs imposed on Chinese goods earlier this year. The levy drops from 20 percent to 10 percent, a move that formalizes the centerpiece of a larger agreement struck between Washington and Beijing after Trump and Chinese President Xi Jinping met in Busan, South Korea, last month.
The original 20 percent tariff had been Trump's response to what he characterized as China's role in the distribution network supplying fentanil to American markets. The synthetic opioid has become a defining public health crisis in the United States, and the administration had made addressing its flow a priority in trade negotiations.
Under the terms now formalized by the decree, China has committed to stopping the shipment of precursor chemicals and materials used to manufacture fentanil. These are the building blocks traffickers need; cutting off their supply at the source was the theory behind the original tariff threat. In exchange, the United States agreed to reduce the penalty on Chinese imports, with the new 10 percent rate taking effect on November 10.
Trump emphasized that American officials will be responsible for verifying China's compliance with the agreement. The monitoring mechanism is built into the deal itself—a recognition that trust alone will not suffice. If Beijing fails to hold up its end, the implication is clear: the tariffs could snap back to their original level, and the broader trade relationship could deteriorate further.
The agreement represents a rare moment of cooperation between the two largest economies on a shared problem. Fentanil trafficking has killed tens of thousands of Americans annually, and the crisis has touched communities across the country regardless of geography or wealth. For Trump, the deal offered a way to claim a win on both fronts: addressing a domestic emergency while also securing a trade concession that reduces costs for American importers and consumers.
What remains to be seen is whether the arrangement will hold. China's incentive to comply is the tariff reduction itself—a meaningful economic benefit. But enforcement of such agreements has proven difficult in the past, and the opioid supply chain is complex and often opaque. The next months will test whether the agreement becomes a genuine turning point in the fentanil crisis or simply another layer of diplomatic theater.
Notable Quotes
Trump emphasized that American officials will be responsible for verifying China's compliance with the agreement— Trump administration statement
The Hearth Conversation Another angle on the story
Why would Trump cut the tariffs in half rather than wait to see if China actually stops the fentanil shipments first?
Because China needed something concrete to show its own leadership—proof that cooperation would be rewarded. Without the tariff reduction on the table, Beijing had little incentive to move. This way, both sides get something immediately, and the monitoring happens afterward.
But that seems backward. Shouldn't the US verify compliance before lowering the penalty?
In theory, yes. But trade negotiations don't work that way. You have to give something to get something. Trump's betting that the tariff reduction is valuable enough to China that they'll actually enforce it on their end. If they don't, the tariffs go back up.
How would anyone even know if China is complying? Fentanil precursors aren't exactly tracked like oil shipments.
That's the hard part. The agreement says American officials will monitor it, but monitoring a chemical supply chain that crosses multiple countries and often moves through shell companies is nearly impossible. You're looking for something that's designed to be hidden.
So this could just be theater—both sides claiming victory while nothing actually changes on the ground?
It could be. But it's also possible that China, facing the tariff threat, actually does tighten controls on its chemical exports. The incentive is there. Whether it works depends on whether Beijing wants to maintain the trade relationship more than it wants the money from fentanil precursor sales.
And if it doesn't work?
Then Trump reimposed the tariffs, and you're back to a trade war. The real test comes in the next six months.